The Incidence, Mechanisms, and Clinical Impact of Tacrolimus-Associated Thrombotic Microangiopathy in Kidney Transplant Recipients: A Multicenter Retrospective Cohort Study
Transplantation Proceedings · 2025
DOI: 10.1016/j.transproceed.2025.07.028 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Transplantation Proceedings, 2025. Verfasst von Ahmad Matarneh und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Pennsylvania State Milton S. Hershey Medical Center, Hershey, Pennsylvania. Electronic address: Ahmadmatarneh99@gmail.com. Hauptthemen laut MEDLINE: Tacrolimus, Thrombotic Microangiopathies, Kidney Transplantation, Immunosuppressive Agents. Die Arbeit nennt 19 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Thrombotic microangiopathy (TMA) represents a critical and potentially devastating complication in kidney transplantation. Characterized by microvascular thrombosis, hemolytic anemia, and organ dysfunction, TMA poses significant risks to kidney transplant recipients. Among these patients, calcineurin inhibitors (CNIs) like tacrolimus have been implicated in TMA pathogenesis due to their ability to induce endothelial injury. This study aims to investigate the incidence of tacrolimus-related TMA and its clinical outcomes, hypothesizing that tacrolimus usage correlates with a higher incidence of TMA and poorer clinical outcomes compared to alternative immunosuppressive therapies. METHODS: We conducted a multicenter retrospective analysis utilizing data from the TriNetX global health research network, examining 1252 kidney transplant recipients on tacrolimus and 290 on alternative immunosuppressive regimens. We assessed the incidence of TMA, rates of graft rejection and failure, and 5-year patient survival. Statistical analyses were performed, including adjusted relative risks (RR) and Kaplan-Meier survival curves. RESULTS: The incidence of TMA was significantly higher in tacrolimus-treated patients (40.3%) compared to those on non-tacrolimus regimens (24.4%) (RR = 0.613, 95% CI = 0.495-0.760, P < .001). The 5-year survival rate was notably lower in the tacrolimus cohort (36.1%) compared to the non-tacrolimus group (77.3%) (RR = 0.379, 95% CI = 0.291-0.495, P < .001). Additionally, higher rates of graft rejection (43.1%) and graft failure (38.6%) were observed among tacrolimus recipients. CONCLUSION: Tacrolimus use in kidney transplant recipients was associated with a higher incidence of thrombotic microangiopathy, increased graft rejection and failure, and reduced 5-year survival. However, these findings are limited by the retrospective design, reliance on diagnosis codes, lack of detailed clinical and medication data, and absence of confounder adjustment. Prospective studies are needed to validate these associations and guide immunosuppressive strategies in high-risk patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, Pennsylvania State Milton S. Hershey Medical Center, Hershey, Pennsylvania. Electronic address: Ahmadmatarneh99@gmail.com.
- Department of Nephrology, Pennsylvania State Milton S. Hershey Medical Center, Hershey, Pennsylvania.
- Department of Nephrology, University of Missouri- Kansas City, Missouri.
- College of medicine, Pennsylvania state university, State College, Pennsylvania.
Zitieren
APA
Matarneh, A., Sardar, S., Salameh, O., Cruise, J., Miller, R., Karasinski, A., Shah, V., Verma, N., Kaur, G., Trivedi, N., Farooq, U., & Ghahramani, N. (2025). The Incidence, Mechanisms, and Clinical Impact of Tacrolimus-Associated Thrombotic Microangiopathy in Kidney Transplant Recipients: A Multicenter Retrospective Cohort Study. Transplantation Proceedings. https://doi.org/10.1016/j.transproceed.2025.07.028
Vancouver
Matarneh A, Sardar S, Salameh O, Cruise J, Miller R, Karasinski A, et al. The Incidence, Mechanisms, and Clinical Impact of Tacrolimus-Associated Thrombotic Microangiopathy in Kidney Transplant Recipients: A Multicenter Retrospective Cohort Study. Transplantation Proceedings. 2025. doi:10.1016/j.transproceed.2025.07.028
BibTeX
@article{Matarneh2025,
author = {Matarneh, Ahmad and Sardar, Sundus and Salameh, Omar and Cruise, Jesse and Miller, Ronald and Karasinski, Amanda and Shah, Vaqar and Verma, Navin and Kaur, Gurwant and Trivedi, Naman and Farooq, Umar and Ghahramani, Nasrollah},
title = {The Incidence, Mechanisms, and Clinical Impact of Tacrolimus-Associated Thrombotic Microangiopathy in Kidney Transplant Recipients: A Multicenter Retrospective Cohort Study},
journal = {Transplantation Proceedings},
year = {2025},
doi = {10.1016/j.transproceed.2025.07.028}
}
EUVIMED